Drug intelligence / Profile preview

AlloStem

Development stage
Preclinical
Lead developer
AlloSource
Modality
Stem Cell Therapies → Cell Therapies
Administration
Implant
01

Overview

**AlloStem** is an AlloSource human cellular bone allograft used as a surgical bone-graft substitute in subtalar arthrodesis. It consists of partially demineralized allogeneic bone matrix seeded with viable adipose-derived mesenchymal stem cells. When implanted at the fusion site with rigid internal fixation, the graft is intended to provide an osteoconductive scaffold, osteoinductive bone-matrix signals, and osteogenic viable cells that support bone formation and fusion. In the randomized AlloStem-versus-autologous-bone-graft subtalar arthrodesis study, 140 patients were enrolled and 124 underwent surgery; CT-based fusion was assessed at 6 months. ([boneandjoint.org.uk](https://boneandjoint.org.uk/Article/10.1302/1358-992X.2024.7.015))

Brand names
AlloStem
Other names
AlloStem Cellular Bone Allograft

Beyond the preview

Go deeper on AlloStem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlloStem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call